Jiangsu Recbio Technology Co., Ltd.

US drug maker Merck & Co., Inc. ( MSD outside North America) is known for its best-selling immuno-oncology agents and vaccines and delivered a high-flying performance in China last year, despite ri

China’s first homegrown vaccine for herpes zoster (shingles), Ganwei, developed by Changchun BCHT Biotechnology Co. (BCHT), had a strong commercial launch in 2023, setting the stage for a showdown w

Six Chinese biotechs are reshuffling their research and development programs to conserve funds amid the persistent downturn in the sector, the companies disclosed in their annual results for 2022. Whi

Chinese biotechs closed the first quarter with three additional initial public listings in Shanghai and Hong Kong, grossing a combined $742.9m in the last weeks of March. While the number of new listi